Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
48 /100
MEDIUM RISK
Score updated Oct 27, 2026

VANI — Vivani Medical, Inc. Dilution Risk Tracker

Track VANI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VANI — Get alerts when the score changes →

As of October 27, 2026, Vivani Medical, Inc. (VANI) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Vivani Medical, Inc. has a market capitalization of $104.18M, 90.20M shares outstanding, 45 institutional holders tracked. Stored dilution-related fields include 10.1K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
65
📊 Float Risk
37
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 24%
🔄 Reverse Split model est. 40%
• 50-day avg $1.20 approaching $1 threshold
• 10 months cash with weak price
💰 Capital Raise model 15%
• Under 12 months cash (10mo)
🔔 Track VANI — Get forecast alerts →

Market Data

Market Cap$104.18M
Shares Outstanding90.20M
Float38.86M
Cash$19.89M
Debt$2.20M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore48/100DilutionWatch score record
Shares Outstanding90.20MVerified float table or market cache
Public Float38.86MVerified float table or market cache
Market Cap$104.18MMarket data cache
Cash Runway10.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants10.1KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: FORM 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

VANI SEC Filing Activity — Last 12 Months

Shares outstanding reported by VANI on the cover page of its latest 10-K/10-Q: 90.20M as of August 13, 2026.

DilutionWatch recorded 1 registration or prospectus document for VANI (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
424B5prospectus supplement (ATM / shelf takedown)1Sep 25, 2026
8-Kcurrent report (material event)8Sep 16, 2026
10-Kannual report1Mar 26, 2026
10-Qquarterly report1May 13, 2026
DEF 14Aproxy statement1Apr 29, 2026
4insider transaction14Oct 19, 2026
3initial insider ownership2Jun 26, 2026

Institutional Holdings

QoQ: ↑ 31.3% shares (2026Q1 vs prior)
45 institutional holders · 7.25M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 3.06M shares
#2 Tanager Wealth Management LLP 641.1K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 600.6K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest417.1K
Days to Cover2.8
% of Float1.1%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-03-31
xbrl XBRL CONVERTIBLE 2017-03-16
Form 4 INSIDER TRANSACTION 2026-07-28
Form 4 INSIDER TRANSACTION 2026-07-28
Form 4 INSIDER TRANSACTION 2026-07-28
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VANI Dilution Snapshot

Vivani Medical, Inc. (VANI) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VANI's DilutionScore is currently 48/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 52/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 27, 202648/100MEDIUM67 days
Aug 14 – Aug 21, 202652/100HIGH7 days
Jul 30 – Aug 13, 202648/100MEDIUM15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

VANI shares outstanding have increased 1.9% from 84.65M (Mar 2026) to 86.24M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 202686.24M38.86M▲ 1.88%
May 11, 202686.24M38.14M▲ 2.34%
Apr 26, 202684.65M37.27M▼ 4.08%
Apr 03, 202684.65M38.86M▲ 7.61%
Mar 30, 202684.65M36.11M▲ 10.90%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track VANI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VANI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VANI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VANI
VANI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.